Neoplasia/BPH

	Comparison of biparametric and multiparametric MRI for detection of clinically significant prostate cancer using PI-RADS v2.1. Curr Probl Diagn Radiol Kulkarni CB, Mishra AK. PMID: 43034132 [PubMed - as supplied by publisher]
	Histological Subtypes, Divergent Differentiation, and Neuroendocrine Components in Primary Non-Muscle-Invasive Bladder Cancer Managed with Bladder-Preserving Approaches: A Propensity Score-Matched Study. Clin Genitourin Cancer Ekenci BY, Sar, Durak HM, Karakoyunlu AN. PMID: 43034119 [PubMed - as supplied by publisher]
	Preoperative prediction of complications after robot-assisted radical prostatectomy: development and internal validation of a prediction model compared with generic risk scores. World J Urol Kasim RH, Ghijselings L, Buhas BA, Potiron E, Miaadi N, Pasticier G, Deffar N, Vuong NS, Gourtaud G, Beauval JB, Roumiguié M, Rouffilange J, Pettenati C, Filler T, Brureau L, Bommelaere T, Dariane C, Ploussard G. PMID: 43033230 [PubMed - indexed for MEDLINE]
	Efficacy of HER2-targeted therapies in localized urothelial carcinoma: a systematic review and meta-analysis. World J Urol Suleja A, Bret D, Miszczyk M, Dong W, Zhou X, Laukhtina E, Englinger B, Rajwa P, Karakiewicz PI, Achard V, Szabados B, Compérat E, Rosenberg JE, Zhou P, Shariat SF. PMID: 43033227 [PubMed - indexed for MEDLINE]
	Charting the landscape of microbiota in bladder cancer: Molecular mechanisms and therapeutic implications. Genes Dis Luo Z, Xu D, Wang Z, Wu L, Ou C, Ou Z. PMID: 43032399 [PubMed]
	Terminal digit preference: A potential bias in radiographic and pathologic evaluations of kidney cancer- retrospective single center study. Ther Adv Urol Gofrit ON, Yutkin V, Appelbaum L, Lorber A, Duvdevani M, Zuaiter M, Hidas G, Neuman T. PMID: 43031874 [PubMed]
	Urinary biomarker-guided surveillance versus standard cystoscopic surveillance for non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials. World J Urol Abushamma F, Abdalrazeq H, Hajjeh O, Algharaba S, Salameh H, Jarrad L, Zyoud SH, Malhis R, Pfister D, Rieger C, Weiten R, Heidenreich A. PMID: 43034244 [PubMed - indexed for MEDLINE]
	Adverse event profiles of immune checkpoint inhibitor-based strategies for metastatic prostate cancer: a systematic review and network meta-analysis. Front Med (Lausanne) Wang Q, Hao C, Chen J, Wang W, Zhang H. PMID: 43031762 [PubMed]
	Multimodal CT radiomics and 2.5D deep learning for preoperative grading of clear cell renal cell carcinoma in older patients: a multicenter study. Front Oncol Wang Z, Liang Z, Lv D, Hu S, Zhou H, Li J, Bian X, Gao J, Zhao T, Gong B, Qiao Y, Shuang W. PMID: 43031732 [PubMed]
	The Relationship Between Pre-Operative Ipilimumab and Nivolumab Pharmacokinetics and Treatment Outcome in LocoregionallyÂ Advanced Urothelial Cancer. Clin Transl Sci Zielhuis SWJ, de Jong KAM, Huisman-Siebinga H, van der Heijden LT, Jacobs BAW, Beijnen JH, Rosing H, Stockem CF, van Dorp J, van der Heijden MS, Huitema ADR. PMID: 43031519 [PubMed - indexed for MEDLINE]
	Hypoxia-inducible factor 2Î± inhibition in renal cell carcinoma: From von Hippel-Lindau biology to targeted therapeutics. Cancer Chen YW, Sano F, McKay RR. PMID: 43031368 [PubMed - indexed for MEDLINE]
	Integration of individual-level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer. Cancer Jung W, Hettinger G, Narayan V, Mei L, Takvorian S, Martei YM, Clark A, Huang A, Mcdermott K, Smith AM, Xia C, Ko K, Pagan JS, Koropeckyj-Cox D, Getz K, Guerra CE, Fayanju OM, Kumar S, Beyer KMM, Powell-Wiley T, Yancy C, Park YM, Ky B. PMID: 43031355 [PubMed - indexed for MEDLINE]
	Phospho-LATS1/2 Immunoreactivity and Survival in Muscle-Invasive Bladder Cancer: A Quantitative Immunohistochemical Study. Int J Urol Kakita S, Matsuo T, Otsubo A, Araki K, Honda H, Mori S, Mitsunari K, Ohba K, Imamura R. PMID: 43031265 [PubMed - indexed for MEDLINE]
	Oligoprogression and Metastasis-Directed Therapy During Systemic Therapy for Metastatic Renal Cell Carcinoma. Int J Urol Shimizu T, Oda Y, Nishimura N, Iemura Y, Iida K, Tatsumi Y, Sakamoto K, Iwamoto T, Ichikawa K, Kuwada M, Takamatsu N, Tachibana A, Tomizawa M, Onishi K, Hori S, Morizawa Y, Dotoh D, Nakai Y, Tanaka N, Miyake M. PMID: 43031260 [PubMed - indexed for MEDLINE]
	Clinical Outcomes of Percutaneous Cryoablation for Localized Renal Cell Carcinoma in Very Elderly Patients. Int J Urol Okuda Y, Kato T, Nagahara A, Uemura M, Ono Y, Higashihara H, Yoshimura A, Tani M, Horibe Y, Oka T, Uemura T, Yamamoto A, Yamamichi G, Ishizuya Y, Hayashi T, Yamamoto Y, Hatano K, Kawashima A, Nonomura N. PMID: 43031252 [PubMed - indexed for MEDLINE]
	Impact of a Reminder App on Bladder Filling During Moderately Hypo-Fractionated Radiotherapy for Prostate Cancer: Results of the REFILL-PAC-HYPO Trial. J Clin Med Rades D, Janssen S, Doehring L, Küter JD, Staden MV, Al-Salool A, Koeck J, Domschikowski J, Schulz CF, Cacicedo J, Vestergård Madsen C, Kristiansen C. PMID: 43030701 [PubMed]
	From Radical Treatment to Structured Active Surveillance: A Narrative Review of Low-Risk Localized Prostate Cancer. J Clin Med Rodríguez-Parras P, Román-Ramos P, Zambudio-Munuera A, Arrabal-Polo MÁ. PMID: 43030434 [PubMed]
	Clinical Risk Models, Inflammatory-Nutritional Indices and a Neural-Network Survival Model in Metastatic Renal Cell Carcinoma: A Single-Center Retrospective Study. J Clin Med Sali M, Yigit E, Ard, Sali S, Coskun A, Ozcelik EE, Özmarasal, Akta, Sahin AB, Çubukçu E, Evrensel T, Deligönül A. PMID: 43030405 [PubMed]
	Pre-Diagnosis Metabolic Health-Related Dietary Index and Prostate Cancer-Specific Mortality. Nutrients Msibi SS, Woldehawariat K, Trinh N, Lee M, Su LJ. PMID: 43030330 [PubMed - indexed for MEDLINE]
	Protective Effects of Achyranthes bidentata Root Extract Against Benign Prostatic Hyperplasia Induced by Testosterone Propionate in Rats. Nutrients Kim HK, Tran P, Kim S, Song J. PMID: 43030201 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 192902

Page 1 of 9646



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy